Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma

International Journal of Cancer

Volumn 119, Issue 7, 2006, Pages 1648-1653

  Shimakage, Misuzu ^a,i   Inoue, Nobumasa ^a   Ohshima, Kohichi ^b,g   Kawahara, Kunimitsu ^a,h   Oka, Takashi ^c   Yasui, Kazuta ^d   Matsumoto, Kayoko ^d   Inoue, Hirokazu ^e   Watari, Akihiro ^f   Higashiyama, Shinji ^f   Yutsudo, Masuo ^f  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d OSAKA RED CROSS HOSPITAL   (Japan)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^f OSAKA UNIVERSITY   (Japan)

^g KURUME UNIVERSITY   (Japan)

^h OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

ⁱ National Hospital Organization Wakayama Hospital   (Japan)

Author keywords

ASY Nogo; ATLL; mRNA in situ hybridization; Progression; Tax

Indexed keywords

ADULT; ARTICLE; ASY GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; NOGO GENE; PRIORITY JOURNAL; T CELL LYMPHOMA; TAX GENE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE PRODUCTS, TAX; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYELIN PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 33747470604     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22011     Document Type: Article

References (22)

1. Poietz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-9.
2. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-92.
3. Shimoyama M, Members of Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia/lymphoma. Br J Haematol 1991;79:428-37.
4. Neuveut C, Low KG, Maldarelli F, Schmitt I, Majone F, Grassmann R, Jeang KT. Human T-cell leukemia virus type 1 tax and cell cycle progression: role of cyclin D-cdk and p110RB. Mol Cell Biol 1998;18:3620-32.
5. Pozzatti R, Vogel J, Jay G. The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol Cell Biol 1990;10:413-7.
6. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Ann Rev Immunol 2001;19:475-96.
7. Jeang K-T, Giam C-Z, Majone F, Aboud M. Life, death and tax: role of HTLV-1 oncoprotein in genetic instability and cellular transformation. J Biol Chem 2004;279:31991-4.
8. Li Q, Qi B, Oka K, Shimakage M, Yoshioka N, Inoue H, Hakura A, Kodama K, Stanbridge EJ, Yutsudo M. Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene 2001;20:3929-36.
9. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell AA, Christ F, Schwab ME. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibodyIN-1. Nature 2000;403:434-39.
10. GrandPre T, Nakamura F, Vartian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000;403:439-4.
11. Okamoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, Tajima K, Miwa M, Shimotohno K. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res 1989;80:191-5.
12. Nishimura S, Asou N, Suzushima H, Okubo T, Fujimoto T, Osato M, Yamasaki H, Lisha L, Takatsuki K. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia. Leukemia 1995;9:598-604.
13. Fujiwara H, Arima N, Hashimoto-Tamaoki T, Matsushita K, Ohtsubo H, Arimura K, Hidaka S, Tei C. Alteration of p16 (CDKN2) gene is associated with interluekin-2-induced tumor cell growth in adult T-cell leukemia. Exp Hematol 1999;27:1004-9.
14. Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res 2000;15:1043-8.
15. Nakayama K, Yamada Y, Koji T, Hayashi T, Tomonaga M, Kamihira S. Expression and phosphorylation status of retinoblastoma protein in adult T-cell leukemia/lymphoma. Leukemia Res 2000;24:299-305.
16. Arima N, Matsushita K, Obata H, Ohtsubo H, Fujiwara H, Arimura K, Kukita T, Suruga Y, Wakamatsu S, Hidakas, Tei C. NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications. Exp Hematol 1999;27:1168-75.
17. Tambe Y, Isono T, Haraguchi S, Yoshioka-Yamashita A, Yutsudo M, Inoue H. A novel apoptotic pathway induced by the drs tumor suppressor gene. Oncogene 2004;23:2977-87.
18. Tsujimoto Y, Ikegami N, Croce CM. Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 1987;2:3-7.
19. Inukai T, Inoue A, Kurosawa H, Goi K, Shinjyo T, Ozawa K, Mao M, Inaba T, Look A. SLUG, a ces-1-related zinc finger transcription gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol Cell 1999;4:343-52.
20. Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA. IL-2Rα-directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Rα interaction. Cancer Res 2000;15:6977-84.
21. Tamiya S, Matsuoka M, Etoh K-I, Watanabe T, Kamihira S, Yamaguchi K, Takatsuki K. Two types of defective human T-lymphotropic virus type I (HTLV-I) provirus in adult T-cell leukemia. Blood 1996;88:3065-73.
22. Ohshima K, Suzumiya J, Izumo S, Mukai Y, Tashiro K, Kikuchi M. Detection of human T-lymphotropic virus type-I DNA and mRNA in lymph nodes; using polymerase chain reaction in situ hybridization (PCR/ISH) and reverse transcription (RT-PCR/ISH). Int J Cancer 1996;66:18-23.